Psychology › Section P · Therapy and treatment › Topic P.4

Treating substance-related and addictive disorders

Addiction is treated differently from most disorders because it tends to last, to return after periods of recovery, and to tangle with health, family, work and the law. This topic explains how treatment is organised and what the evidence says works. It is education only, never advice about anyone's use or treatment.

Why addiction is a special case

The earlier substance use topic described how psychoactive drugs act on the brain. The DSM-5-TR groups problem use under substance use disorders, rated mild, moderate or severe according to how many criteria are met, such as craving, failed attempts to cut down, tolerance, withdrawal and continued use despite harm. It also recognises one behavioural addiction, gambling disorder. Treating these conditions raises special issues: many people are ambivalent about stopping, physical withdrawal may need medical care, other mental health problems often occur at the same time, and setbacks are common. Only a qualified clinician can assess whether someone has one of these disorders.

A chronic, relapsing condition

The US National Institute on Drug Abuse (NIDA) describes addiction as a chronic disease of the brain. For most people, first use is a choice, but repeated use changes reward circuits and the prefrontal cortex, which supports judgement and self-control, so use becomes increasingly compulsive. Relapse, a return to use after a period of improvement, is common: NIDA estimates that 40% to 60% of people treated for substance use disorders relapse, comparable to the 50% to 70% at which people with hypertension or asthma see symptoms return. Some researchers argue that the disease model underplays choice, social conditions and natural recovery, and many people do recover, with or without formal treatment.

The goals of treatment

The central goal is to stop compulsive drug seeking and use and to help the person function well at home, at work and in the community. Many programmes aim for abstinence, stopping use completely. Others accept a significant, lasting reduction as a valid goal, especially at first. Harm reduction is a public health approach that aims to reduce the damage drug use causes even while use continues, for example by distributing naloxone, a medication that can reverse an opioid overdose, and by providing sterile syringes. Because addiction is long-lasting, treatment is often long-term, like the management of other chronic illnesses.

Withdrawal management and medications

Withdrawal management, often called detox, helps a person stop a substance safely. It is only a first step, not treatment by itself. Withdrawal from alcohol or from sedatives such as benzodiazepines can cause seizures and can be life-threatening, so it should happen under medical supervision. Medications are an important part of treatment for some substances. For opioid use disorder, methadone, buprenorphine and naltrexone reduce cravings or block opioid effects; methadone and buprenorphine in particular lower the risk of overdose death. Other medications are approved for alcohol use disorder and for quitting tobacco. Any medication decision belongs with a prescriber.

Behavioural therapies

Behavioural therapies are the backbone of most treatment. Cognitive-behavioural therapy for substance use teaches people to recognise situations that trigger use and to build skills for handling cravings and preventing relapse. Contingency management applies operant conditioning: people earn rewards, such as vouchers, for verified drug-free tests, and it has strong evidence for stimulant use, for which no medication is yet approved. Motivational interviewing, developed by William Miller and Stephen Rollnick, is a collaborative conversation style that helps people resolve their own ambivalence about change rather than being lectured or confronted. Twelve-step facilitation helps people engage with mutual-help groups.

Worked example: a relapse-prevention plan

In CBT for substance use, client and therapist build a relapse-prevention plan together. Consider Sam, who is three weeks into treatment for alcohol use disorder. 1. High-risk situations: Friday evenings with colleagues at a bar, and evenings alone after an argument. 2. Coping skills for each: arranging non-drinking plans with supportive friends on Fridays, and calling his sponsor or going for a run after conflict. 3. Warning signs: skipping group meetings and telling himself one drink will not matter. 4. A lapse plan: if he drinks, he will contact his therapist the next day rather than treating the slip as total failure. Check: the plan anticipates triggers in advance and treats a lapse as information, not as the end of recovery.

What makes treatment effective

Research summarised by NIDA points to several principles. No single treatment suits everyone, so plans should match the person. Staying in treatment long enough matters: many people need at least three months to reduce or stop use substantially. Effective treatment addresses the whole person, including medical problems, mental health, relationships, parenting, housing, work and legal issues, not just the drug use. Group therapy is the most widely used format, valued for support and identification with others, though studies have not found it clearly better than individual therapy. For teenagers, involving the family improves outcomes. Treatment is also far cheaper for society than imprisonment or no treatment.

Co-occurring disorders

Many people with a substance use disorder also have another mental health condition, such as depression, an anxiety disorder, PTSD, bipolar disorder or schizophrenia. Having two or more disorders at once is called comorbidity, or co-occurring disorders. The relationship runs both ways. Heavy substance use can produce or worsen symptoms of mood and anxiety disorders, and people with distressing symptoms may use substances to cope, sometimes called self-medication. Shared risk factors, such as trauma, stress and genetic vulnerability, can contribute to both. Current guidance is that both conditions should be treated at the same time in a coordinated, integrated way, rather than insisting one be resolved first.

Worked example: integrated treatment

Maya, 24, has panic attacks and has been drinking heavily to calm them. Compare two approaches. 1. Sequential approach: one clinic insists she stop drinking before it treats her anxiety. Without help for the panic, her main reason for drinking remains, so relapse is likely. 2. Integrated approach: a single team treats both together. 3. Anxiety side: CBT and exposure teach her to ride out panic sensations without escaping them. 4. Substance side: relapse-prevention skills and motivational interviewing address her drinking. 5. Link: the team shows her how drinking eases panic briefly but makes anxiety worse the next day. Check: because each problem feeds the other, treating them together addresses the cycle, which is why integrated care is recommended.

Common mistakes to avoid

First, treating detox as the whole of treatment: it is only the first step. Second, seeing relapse as proof that treatment failed: relapse rates resemble those of other chronic illnesses and often signal a need to adjust treatment. Third, assuming addiction medications simply swap one addiction for another: medications such as buprenorphine are evidence-based and lower overdose deaths. Fourth, believing confrontation works best: collaborative approaches such as motivational interviewing are better supported. Fifth, treating co-occurring disorders one at a time. Sixth, thinking alcohol withdrawal is always mild: it can be medically dangerous.

Key takeaways

Substance use disorders range from mild to severe, and gambling disorder is the DSM-5-TR's one behavioural addiction. NIDA describes addiction as a chronic, relapsing brain condition, with relapse rates of 40% to 60%, though the model is debated. Goals range from abstinence to reduced use, and harm reduction lowers damage along the way. Withdrawal management is a first step; medications help for opioids, alcohol and tobacco. CBT, contingency management and motivational interviewing are well supported. Effective treatment is tailored, long enough and holistic, and co-occurring disorders are treated together. For help in the US, the free SAMHSA National Helpline is 1-800-662-4357, and anyone in crisis can call or text 988.

Flashcards

Flashcard

Substance use disorder

DSM-5-TR diagnosis rated mild, moderate or severe

Based on how many criteria are met.

Test your understanding

Question 1 of 5

Why does NIDA compare addiction to illnesses such as hypertension and asthma?

Question 2 of 5

Distributing naloxone to people who use opioids is an example of:

Question 3 of 5

A programme gives vouchers to clients each time they provide a drug-free test. This approach is called:

Question 4 of 5

Which statement about withdrawal management (detox) is accurate?

Question 5 of 5

A client has depression and a cannabis use disorder. What does current guidance recommend?

← Previous topicNext topic →